These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 20234303)

  • 1. Statistical evaluation of a biomarker.
    Ray P; Le Manach Y; Riou B; Houle TT
    Anesthesiology; 2010 Apr; 112(4):1023-40. PubMed ID: 20234303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence-based medicine, systematic reviews, and guidelines in interventional pain management: part 6. Systematic reviews and meta-analyses of observational studies.
    Manchikanti L; Datta S; Smith HS; Hirsch JA
    Pain Physician; 2009; 12(5):819-50. PubMed ID: 19787009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized controlled trials 4: Biomarkers and surrogate outcomes.
    Rigatto C; Barrett BJ
    Methods Mol Biol; 2015; 1281():207-24. PubMed ID: 25694312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Introduction to the development and validation of predictive biomarker models from high-throughput data sets.
    Deng X; Campagne F
    Methods Mol Biol; 2010; 620():435-70. PubMed ID: 20652515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictive biomarkers for treatment selection: statistical considerations.
    Chen JJ; Lu TP; Chen YC; Lin WJ
    Biomark Med; 2015; 9(11):1121-35. PubMed ID: 26507127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Biomarker-Surrogacy Evaluation Schema: a review of the biomarker-surrogate literature and a proposal for a criterion-based, quantitative, multidimensional hierarchical levels of evidence schema for evaluating the status of biomarkers as surrogate endpoints.
    Lassere MN
    Stat Methods Med Res; 2008 Jun; 17(3):303-40. PubMed ID: 17925313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tom Ten Have's contributions to causal inference and biostatistics: review and future research directions.
    Small DS; Joffe MM; Lynch KG; Roy JA; Russell Localio A
    Stat Med; 2014 Sep; 33(20):3421-33. PubMed ID: 23255088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Statistical evaluation of biomarkers as surrogate endpoints: a literature review.
    Weir CJ; Walley RJ
    Stat Med; 2006 Jan; 25(2):183-203. PubMed ID: 16252272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new functional data-based biomarker for monitoring cardiovascular behavior.
    Zhou Y; Sedransk N
    Stat Med; 2013 Jan; 32(1):153-64. PubMed ID: 22886476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lessons in biostatistics: inferences and conjectures about average and conditional treatment effects in randomized trials and observational studies.
    Bottai M
    J Intern Med; 2014 Sep; 276(3):229-37. PubMed ID: 25040872
    [No Abstract]   [Full Text] [Related]  

  • 11. Could the use of biochemical validation of smoking abstinence introduce a confound into the interpretation of randomized controlled trials of tobacco cessation?
    Cunningham JA; Kushnir V
    Addiction; 2013 Apr; 108(4):827-8. PubMed ID: 23496073
    [No Abstract]   [Full Text] [Related]  

  • 12. Evaluating the evidence: statistical methods in randomized controlled trials in the urological literature.
    Scales CD; Norris RD; Preminger GM; Vieweg J; Peterson BL; Dahm P
    J Urol; 2008 Oct; 180(4):1463-7. PubMed ID: 18710745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recommendations for reporting randomized controlled trials of herbal interventions: Explanation and elaboration.
    Gagnier JJ; Boon H; Rochon P; Moher D; Barnes J; Bombardier C;
    J Clin Epidemiol; 2006 Nov; 59(11):1134-49. PubMed ID: 17027423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biomarkers in terrestrial invertebrates for ecotoxicological soil risk assessment.
    Kammenga JE; Dallinger R; Donker MH; Köhler HR; Simonsen V; Triebskorn R; Weeks JM
    Rev Environ Contam Toxicol; 2000; 164():93-147. PubMed ID: 12587835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Statistical and scientific inference.
    Ahlbom A
    J Intern Med; 2014 Sep; 276(3):238-9. PubMed ID: 25040681
    [No Abstract]   [Full Text] [Related]  

  • 16. Interim treatment selection with a flexible selection margin in clinical trials.
    Wu Y; Zhao PL
    Stat Med; 2013 Jul; 32(15):2529-43. PubMed ID: 23212767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improving the quality of reporting of randomized controlled trials evaluating herbal interventions: implementing the CONSORT statement [corrected].
    Gagnier J; Boon H; Rochon P; Barnes J; Moher D; Bombardier C;
    Explore (NY); 2006 Mar; 2(2):143-9. PubMed ID: 16781628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjustment for the measurement error in evaluating biomarkers.
    Li W; Qu Y
    Stat Med; 2010 Sep; 29(22):2338-46. PubMed ID: 20603813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Methodological aspects of biostatistics and epidemiology in a clinical trial].
    Suárez E; Pérez CM
    P R Health Sci J; 1999 Mar; 18(1):23-30. PubMed ID: 10343983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quality of reporting of randomized controlled trials of herbal medicine interventions.
    Gagnier JJ; DeMelo J; Boon H; Rochon P; Bombardier C
    Am J Med; 2006 Sep; 119(9):800.e1-11. PubMed ID: 16945616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.